Literature DB >> 16876206

Pharmacological activation and inhibition of Slack (Slo2.2) channels.

Bo Yang1, Valentin K Gribkoff, Jennifer Pan, Veronique Damagnez, Steven I Dworetzky, Christopher G Boissard, Arin Bhattacharjee, Yangyang Yan, Fred J Sigworth, Leonard K Kaczmarek.   

Abstract

The Slack (Sequence like a calcium-activated K channel) (Slo2.2) gene is abundantly expressed in the mammalian brain and encodes a sodium-activated K+ (KNa) channel. Although the specific roles of Slack channel subunits in neurons remain to be identified, they may play a role in the adaptation of firing rate and in protection against ischemic injury. In the present study, we have generated a stable cell line expressing the Slack channel, and have analyzed the pharmacological properties of these channels in these cells and in Xenopus oocytes. Two known blockers of KNa channels, bepridil and quinidine, inhibited Slack currents in a concentration-dependent manner and decreased channel activity in excised membrane patches. The inhibition by bepridil was potent, with an IC50 of 1.0 microM for inhibition of Slack currents in HEK cells. In contrast, bithionol was found to be a robust activator of Slack currents. When applied to the extracellular face of excised patches, bithionol rapidly induced a reversible increase in channel opening, suggesting that it acts on Slack channels relatively directly. These data establish an important early characterization of agents that modulate Slack channels, a process essential for the experimental manipulation of Slack currents in neurons.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 16876206     DOI: 10.1016/j.neuropharm.2006.06.003

Source DB:  PubMed          Journal:  Neuropharmacology        ISSN: 0028-3908            Impact factor:   5.250


  40 in total

1.  The slack sodium-activated potassium channel provides a major outward current in olfactory neurons of Kv1.3-/- super-smeller mice.

Authors:  Songqing Lu; Paromita Das; Debra A Fadool; Leonard K Kaczmarek
Journal:  J Neurophysiol       Date:  2010-04-14       Impact factor: 2.714

2.  PKA-induced internalization of slack KNa channels produces dorsal root ganglion neuron hyperexcitability.

Authors:  Megan O Nuwer; Kelly E Picchione; Arin Bhattacharjee
Journal:  J Neurosci       Date:  2010-10-20       Impact factor: 6.167

3.  Na+-mediated coupling between AMPA receptors and KNa channels shapes synaptic transmission.

Authors:  Evanthia Nanou; Alexandros Kyriakatos; Arin Bhattacharjee; Leonard K Kaczmarek; Gustavo Paratcha; Abdeljabbar El Manira
Journal:  Proc Natl Acad Sci U S A       Date:  2008-12-18       Impact factor: 11.205

4.  Amino-termini isoforms of the Slack K+ channel, regulated by alternative promoters, differentially modulate rhythmic firing and adaptation.

Authors:  Maile R Brown; Jack Kronengold; Valeswara-Rao Gazula; Charalampos G Spilianakis; Richard A Flavell; Christian A A von Hehn; Arin Bhattacharjee; Leonard K Kaczmarek
Journal:  J Physiol       Date:  2008-09-11       Impact factor: 5.182

Review 5.  Potassium channel modulation and auditory processing.

Authors:  Maile R Brown; Leonard K Kaczmarek
Journal:  Hear Res       Date:  2011-03-21       Impact factor: 3.208

6.  Cardiac metabolic effects of KNa1.2 channel deletion and evidence for its mitochondrial localization.

Authors:  Charles O Smith; Yves T Wang; Sergiy M Nadtochiy; James H Miller; Elizabeth A Jonas; Robert T Dirksen; Keith Nehrke; Paul S Brookes
Journal:  FASEB J       Date:  2018-06-04       Impact factor: 5.191

7.  The Phe932Ile mutation in KCNT1 channels associated with severe epilepsy, delayed myelination and leukoencephalopathy produces a loss-of-function channel phenotype.

Authors:  Katherine M Evely; Kerri D Pryce; Arin Bhattacharjee
Journal:  Neuroscience       Date:  2017-03-31       Impact factor: 3.590

Review 8.  Drug development in the era of precision medicine.

Authors:  Sarah A Dugger; Adam Platt; David B Goldstein
Journal:  Nat Rev Drug Discov       Date:  2017-12-08       Impact factor: 84.694

Review 9.  The need for new approaches in CNS drug discovery: Why drugs have failed, and what can be done to improve outcomes.

Authors:  Valentin K Gribkoff; Leonard K Kaczmarek
Journal:  Neuropharmacology       Date:  2016-03-12       Impact factor: 5.250

10.  Novel therapeutic strategy for neurodegeneration by blocking Aβ seeding mediated aggregation in models of Alzheimer's disease.

Authors:  Simona Eleuteri; Saviana Di Giovanni; Edward Rockenstein; Mike Mante; Antony Adame; Margarita Trejo; Wolf Wrasidlo; Fang Wu; Patrick C Fraering; Eliezer Masliah; Hilal A Lashuel
Journal:  Neurobiol Dis       Date:  2014-08-28       Impact factor: 5.996

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.